Next Article in Journal
Role of Dipeptidyl Peptidase-4 (DPP4) on COVID-19 Physiopathology
Next Article in Special Issue
Subcutaneous Infliximab [CT-P13], a True Biologic 2.0. Real Clinical Practice Multicentre Study
Previous Article in Journal
Tumor Temperature: Friend or Foe of Virus-Based Cancer Immunotherapy
Previous Article in Special Issue
Adalimumab Biosimilar GP2017 versus Adalimumab Originator in Treating Patients with Inflammatory Bowel Diseases: A Real-Life, Multicenter, Observational Study
 
 
Article

Article Versions Notes

Biomedicines 2022, 10(8), 2025; https://doi.org/10.3390/biomedicines10082025
Action Date Notes Link
article pdf uploaded. 19 August 2022 13:56 CEST Version of Record https://www.mdpi.com/2227-9059/10/8/2025/pdf-vor
article xml file uploaded 23 August 2022 04:05 CEST Original file -
article xml uploaded. 23 August 2022 04:05 CEST Update -
article pdf uploaded. 23 August 2022 04:05 CEST Updated version of record https://www.mdpi.com/2227-9059/10/8/2025/pdf-vor
article html file updated 23 August 2022 04:06 CEST Original file -
article pdf uploaded. 9 November 2023 10:49 CET Updated version of record https://www.mdpi.com/2227-9059/10/8/2025/pdf
article xml uploaded. 9 November 2023 10:49 CET Update -
article xml uploaded. 9 November 2023 10:49 CET Update https://www.mdpi.com/2227-9059/10/8/2025/xml
article html file updated 9 November 2023 10:51 CET Update https://www.mdpi.com/2227-9059/10/8/2025/html
Back to TopTop